Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP

Published February 15, 2014

Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP

Filed under: drug treatment programs in san diego

About Lpath San Diego-based Lpath, Inc. (NASDAQ: LPTN), an antibody-platform company, is the category leader in lipid-targeted therapeutics. The company's ImmuneY2™ drug-discovery engine has the unique ability to generate therapeutic antibodies that …
Read more on Benzinga

CEL-SCI Corporation (NYSEMKT:CVM) Posts First-Quarter Results In Line With …

Filed under: drug treatment programs in san diego

Firstly, the company entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Naval Medical Center in San Diego aimed at seeking its approval to undertake Phase I study of its global immunotherapy drug Multikine (Leukocyte …
Read more on WallStreetPR

Training program helps police officers balance safety with sensitivity

Filed under: drug treatment programs in san diego

… Diego Police Department. “The emphasis is sort of like 'armed social work' where the clinician tries to find treatment programs, better family support and medical care for the chronically mentally ill person, while the officer provides protection …
Read more on Lodi News-Sentinel